Pregabalin attenuates dysautonomia as well as painful dysesthesia caused by Guillain-Barré syndrome

Hiroshi Kuroda, Kazuo Fujihara, Ichiro Nakashima, Maki Tateyama, Kimihiko Kaneko, Ohito Tano, Susumu Kusunoki, Masashi Aoki

研究成果: Article

抜粋

Guillain-Barré syndrome (GBS) is frequently accompanied by dysautonomia, which potentially leads to a fatal outcome. Pregabalin binds to the α2δ subunit of voltage-gated calcium channels and has been used as a drug for neuropathic pain. We present a 47-year-old woman who had GBS with severe dysautonomia and painful dysesthesia, in whom pregabalin promptly attenuated both symptoms. After symptoms of respiratory infection lasting a week, she showed mydriatic pupils, ophthalmoparesis, weakness in four limbs with areflexia, cerebellar ataxia and limb dysesthesia. Even after intravenous immunoglobulin therapy was started, her neurological symptoms deteriorated; furthermore, she developed severe dysautonomia including intractable hypertension, bradycardia-tachycardia syndrome, paroxysmal facial flushing and paroxysmal nausea. However, promptly after the first dose of pregabalin, both dysautonomia and dysesthesia were attenuated, and her circulatory condition became stable. Thereafter, her neurological symptoms gradually improved. The present case report suggests that pregabalin can be effective in treating dysautonomia, as well as painful dysesthesia in GBS.

元の言語English
ページ(範囲)75-78
ページ数4
ジャーナルClinical and Experimental Neuroimmunology
4
発行部数1
DOI
出版物ステータスPublished - 2013 6

ASJC Scopus subject areas

  • Neuroscience (miscellaneous)
  • Immunology
  • Immunology and Microbiology (miscellaneous)
  • Clinical Neurology

フィンガープリント Pregabalin attenuates dysautonomia as well as painful dysesthesia caused by Guillain-Barré syndrome' の研究トピックを掘り下げます。これらはともに一意のフィンガープリントを構成します。

  • これを引用